Dr. Paul Auwaerter discusses therapeutics, vaccines, and more about emerging variants of COVID-19.
* Changes to NIH recommendations for mild to moderate COVID-19
* New monoclonal antibody: bebtelovimab
* Monoclonal antibody evasion in omicron sublineages
* Revisions to booster dose schedules for immunocompromised people
Post-test for CME/CE credit: https://covid19.dkbmed.com/multispeci…
Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispeci…
Presenting faculty: Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Ho